Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-020665
Filing Date
2014-11-13
Accepted
2014-11-13 16:03:22
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rpbif20140930_10q.htm 10-Q 1154180
2 EXHIBIT 31.1 ex31-1.htm EX-31 10786
3 EXHIBIT 31.2 ex31-2.htm EX-31 10237
4 EXHIBIT 32.1 ex32-1.htm EX-32 6231
5 EXHIBIT 32.2 ex32-2.htm EX-32 6209
  Complete submission text file 0001437749-14-020665.txt   6687539

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS rpbif-20140930.xml EX-101.INS 1049856
7 EXHIBIT 101.SCH rpbif-20140930.xsd EX-101.SCH 56243
8 EXHIBIT 101.CAL rpbif-20140930_cal.xml EX-101.CAL 33930
9 EXHIBIT 101.DEF rpbif-20140930_def.xml EX-101.DEF 260302
10 EXHIBIT 101.LAB rpbif-20140930_lab.xml EX-101.LAB 334967
11 EXHIBIT 101.PRE rpbif-20140930_pre.xml EX-101.PRE 254677
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50571 | Film No.: 141218382
SIC: 8734 Services-Testing Laboratories